HUE056410T2 - Eljárások a hatóanyagok jobb bejuttatására a tumorokba - Google Patents
Eljárások a hatóanyagok jobb bejuttatására a tumorokbaInfo
- Publication number
- HUE056410T2 HUE056410T2 HUE16831139A HUE16831139A HUE056410T2 HU E056410 T2 HUE056410 T2 HU E056410T2 HU E16831139 A HUE16831139 A HU E16831139A HU E16831139 A HUE16831139 A HU E16831139A HU E056410 T2 HUE056410 T2 HU E056410T2
- Authority
- HU
- Hungary
- Prior art keywords
- tumors
- methods
- active agents
- better delivery
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562196578P | 2015-07-24 | 2015-07-24 | |
| US201562196570P | 2015-07-24 | 2015-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE056410T2 true HUE056410T2 (hu) | 2022-02-28 |
Family
ID=57885141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16831139A HUE056410T2 (hu) | 2015-07-24 | 2016-07-22 | Eljárások a hatóanyagok jobb bejuttatására a tumorokba |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10806913B2 (hu) |
| EP (2) | EP3325080B1 (hu) |
| JP (1) | JP7082041B2 (hu) |
| KR (1) | KR20180035209A (hu) |
| CN (1) | CN107921248A (hu) |
| AU (3) | AU2016297823B2 (hu) |
| BR (1) | BR112018001292A2 (hu) |
| CA (1) | CA2991455C (hu) |
| DK (1) | DK3325080T3 (hu) |
| ES (1) | ES2891523T3 (hu) |
| HU (1) | HUE056410T2 (hu) |
| MX (2) | MX2018000166A (hu) |
| PL (1) | PL3325080T3 (hu) |
| RU (1) | RU2719943C2 (hu) |
| WO (1) | WO2017019526A2 (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017019535A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for lymphatic delivery of active agents |
| HUE056410T2 (hu) * | 2015-07-24 | 2022-02-28 | Sorrento Therapeutics Inc | Eljárások a hatóanyagok jobb bejuttatására a tumorokba |
| CA3063928A1 (en) | 2017-05-17 | 2018-11-22 | Massachusetts Institute Of Technology | Self-righting systems and related components and methods |
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| CN110891923A (zh) | 2017-07-10 | 2020-03-17 | 巴斯夫欧洲公司 | 包含脲酶抑制剂(ui)和硝化抑制剂如2-(3,4-二甲基-1h-吡唑-1-基)琥珀酸(dmpsa)或3,4-二甲基吡唑鎓乙醇酸盐(dmpg)的混合物 |
| US11202903B2 (en) | 2018-05-17 | 2021-12-21 | Massachusetts Institute Of Technology | Systems for electrical stimulation |
| AU2019277577A1 (en) * | 2018-05-31 | 2020-12-24 | Vivasor, Inc. | Drug delivery methods targeting the lymphatic system |
| EP3856321A1 (en) * | 2018-09-24 | 2021-08-04 | L'oreal | Device comprising microneedles for skin-coloring |
| JP2023505231A (ja) | 2019-12-05 | 2023-02-08 | ソレント・セラピューティクス・インコーポレイテッド | リンパ管送達デバイスによる抗ｐｄ－１または抗ｐｄ－ｌ１治療剤の投与による癌の処置方法 |
| WO2022159736A1 (en) | 2021-01-22 | 2022-07-28 | Sorrento Therapeutics, Inc. | Device for microliter-scale lymphatic delivery of coronavirus vaccines |
| WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
| AU2022290563A1 (en) | 2021-06-09 | 2024-01-25 | Vivasor, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
| KR20240056524A (ko) | 2021-08-18 | 2024-04-30 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 림프계를 표적화하는 치료학적 제제 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| BR0106680A (pt) | 2000-06-01 | 2002-04-30 | Watson Pharmaceuticals Inc | Liberação transdermal de lasofoxifeno |
| CN100349629C (zh) * | 2001-09-12 | 2007-11-21 | 贝克顿迪肯森公司 | 用于药物传送的微针为基础的笔装置和使用该装置的方法 |
| CA2529048A1 (en) * | 2003-06-13 | 2005-02-24 | Becton, Dickinson And Company | Improved intra-dermal delivery of biologically active agents |
| AU2004270113A1 (en) | 2003-08-26 | 2005-03-17 | Becton, Dickinson And Company | Methods for intradermal delivery of therapeutics agents |
| US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| WO2006127962A2 (en) * | 2005-05-25 | 2006-11-30 | Becton, Dickinson And Comapny | Particulate formulations for intradermal delivery of biologically active agents |
| WO2006138719A2 (en) * | 2005-06-17 | 2006-12-28 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
| US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
| US8715736B2 (en) | 2009-04-30 | 2014-05-06 | Florida Agricultural And Mechanical University | Nanoparticle formulations for skin delivery |
| CN101829394B (zh) * | 2010-04-27 | 2012-08-22 | 上海交通大学 | 台阶微针阵列的制备方法 |
| WO2011135531A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | MEDICAL DEVICES FOR DELIVERY OF siRNA |
| WO2011135533A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | Nanopatterned medical device with enhanced cellular interaction |
| WO2011135530A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | Device for delivery of rheumatoid arthritis medication |
| EP2563455A4 (en) | 2010-04-28 | 2014-02-19 | Kimberly Clark Co | METHOD FOR INCREASING THE PERMEABILITY OF AN EPITHELIAL BARRIER |
| US20120187814A1 (en) | 2011-01-25 | 2012-07-26 | Fryling Nicholas A | Furniture System and a Frame Assembly for a Furniture System |
| US20120245445A1 (en) * | 2011-03-21 | 2012-09-27 | Michael Darryl Black | Glucose Monitoring System |
| LT2768942T (lt) | 2011-10-17 | 2020-04-10 | Massachusetts Institute Of Technology | Pristatymas į ląstelės vidų |
| JP6100271B2 (ja) * | 2011-10-27 | 2017-03-22 | キンバリー クラーク ワールドワイド インコーポレイテッド | 高粘性生理活性薬剤の経皮的送達 |
| KR101575039B1 (ko) * | 2012-07-19 | 2015-12-07 | (주)아모레퍼시픽 | 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치 |
| ES2851234T3 (es) * | 2012-09-13 | 2021-09-03 | Avraham Amir | Dispositivos de suministro y métodos para aumento cutáneo |
| BR112015006176B1 (pt) | 2012-09-21 | 2023-04-18 | Intensity Therapeutics, Inc | Uso de um agente terapêutico e de um agente de intensificação de permeação intracelular |
| CN103157178B (zh) * | 2013-02-05 | 2014-12-31 | 北京化工大学 | 精确控制微针插入长度的印章式工具 |
| CN109621083B (zh) | 2013-02-28 | 2022-03-22 | 索伦托治疗有限公司 | 药物递送装置 |
| WO2014132239A1 (en) | 2013-02-28 | 2014-09-04 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
| EP2999510A1 (en) | 2013-05-23 | 2016-03-30 | Kimberly-Clark Worldwide, Inc. | Microneedles with improved open channel cross-sectional geometries |
| US10376674B2 (en) * | 2014-09-15 | 2019-08-13 | Ethicon, Inc. | System and method for targeted delivery of therapeutic agents to tissue |
| HUE056410T2 (hu) * | 2015-07-24 | 2022-02-28 | Sorrento Therapeutics Inc | Eljárások a hatóanyagok jobb bejuttatására a tumorokba |
| WO2017019535A2 (en) * | 2015-07-24 | 2017-02-02 | Kimberly-Clark Worldwide, Inc. | Methods for lymphatic delivery of active agents |
-
2016
- 2016-07-22 HU HUE16831139A patent/HUE056410T2/hu unknown
- 2016-07-22 CA CA2991455A patent/CA2991455C/en active Active
- 2016-07-22 AU AU2016297823A patent/AU2016297823B2/en active Active
- 2016-07-22 KR KR1020187003326A patent/KR20180035209A/ko not_active Application Discontinuation
- 2016-07-22 CN CN201680042970.5A patent/CN107921248A/zh active Pending
- 2016-07-22 MX MX2018000166A patent/MX2018000166A/es unknown
- 2016-07-22 US US15/744,346 patent/US10806913B2/en active Active
- 2016-07-22 EP EP16831139.7A patent/EP3325080B1/en active Active
- 2016-07-22 RU RU2018104102A patent/RU2719943C2/ru active
- 2016-07-22 BR BR112018001292A patent/BR112018001292A2/pt not_active Application Discontinuation
- 2016-07-22 PL PL16831139T patent/PL3325080T3/pl unknown
- 2016-07-22 EP EP21189656.8A patent/EP3925599A1/en active Pending
- 2016-07-22 JP JP2018500406A patent/JP7082041B2/ja active Active
- 2016-07-22 ES ES16831139T patent/ES2891523T3/es active Active
- 2016-07-22 DK DK16831139.7T patent/DK3325080T3/da active
- 2016-07-22 WO PCT/US2016/043623 patent/WO2017019526A2/en active Application Filing
-
2018
- 2018-01-08 MX MX2022014277A patent/MX2022014277A/es unknown
-
2020
- 2020-09-16 US US17/022,855 patent/US20210052871A1/en active Pending
-
2021
- 2021-01-12 AU AU2021200146A patent/AU2021200146B2/en active Active
-
2022
- 2022-11-21 AU AU2022275397A patent/AU2022275397A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20180193624A1 (en) | 2018-07-12 |
| JP2018521755A (ja) | 2018-08-09 |
| BR112018001292A2 (pt) | 2018-09-11 |
| JP7082041B2 (ja) | 2022-06-07 |
| AU2022275397A1 (en) | 2023-01-05 |
| PL3325080T3 (pl) | 2022-01-24 |
| KR20180035209A (ko) | 2018-04-05 |
| CN107921248A (zh) | 2018-04-17 |
| CA2991455A1 (en) | 2017-02-02 |
| AU2021200146A1 (en) | 2021-03-18 |
| RU2018104102A (ru) | 2019-08-27 |
| MX2022014277A (es) | 2022-12-07 |
| WO2017019526A2 (en) | 2017-02-02 |
| EP3325080A2 (en) | 2018-05-30 |
| EP3325080A4 (en) | 2019-04-17 |
| EP3925599A1 (en) | 2021-12-22 |
| RU2018104102A3 (hu) | 2019-11-06 |
| MX2018000166A (es) | 2018-03-26 |
| DK3325080T3 (da) | 2021-10-04 |
| EP3325080B1 (en) | 2021-09-01 |
| CA2991455C (en) | 2023-10-10 |
| US20210052871A1 (en) | 2021-02-25 |
| RU2719943C2 (ru) | 2020-04-23 |
| AU2016297823B2 (en) | 2020-10-22 |
| AU2016297823A1 (en) | 2018-02-15 |
| ES2891523T3 (es) | 2022-01-28 |
| US10806913B2 (en) | 2020-10-20 |
| AU2021200146B2 (en) | 2022-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291932B1 (en) | Nanoparticle preparations for prolonged treatment | |
| PL3325080T3 (pl) | Sposoby lepszego dostarczania środków czynnych do guzów | |
| HK1252512A1 (zh) | 向眼部遞送藥劑的方法 | |
| LT3386484T (lt) | Gydomųjų medžiagų sudėtis ir pristatymo metodai | |
| IL249837B (en) | An inhaler for administering active substances through the lungs | |
| HK1258062A1 (zh) | 給予惡拉戈利的方法 | |
| SG10201913124RA (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| IL250677B (en) | Cancer treatment using anti-nkg2a agents | |
| ZA201506916B (en) | Microstructure array for delivery of active agents | |
| IL247722A0 (en) | Pharmaceutical preparations containing active medicinal compounds for the treatment of hematological cancers | |
| IL247721A0 (en) | Pharmaceutical preparations containing active medicinal compounds for the treatment of solid tumors | |
| HK1245834A1 (zh) | 一種b細胞用於體內遞送治療劑 | |
| IL249455A0 (en) | Complexes of mineral-amino acids with active substances | |
| HUE056424T2 (hu) | Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására | |
| PL3021839T3 (pl) | Kompozycje do leczenia zwłóknienia | |
| IL253461A0 (en) | Hydrogels for the release of therapeutic compounds | |
| ZA201700518B (en) | Use of active compound compositions | |
| EP3313380A4 (en) | COMPOSITION FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO AN ANIMAL | |
| PL3142641T3 (pl) | Preparaty do leczenia nadczynności tarczycy | |
| EP3094347A4 (en) | Methods for enhancing the delivery of active agents | |
| SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
| IL240710A0 (en) | Administration of sdf-1 to treat ischemic tissue | |
| AU2013901241A0 (en) | Composition for controlled delivery of therapeutic agents |